NASDAQ:MTFB MOTIF BIO PLC/S (MTFB) Stock Price, News & Analysis → The AI Defense Stock Set to Soar (From Behind the Markets) (Ad) Free MTFB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.10▼$0.1250-Day Range$0.10▼$0.1152-Week Range$0.08▼$11.50Volume867,698 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get MOTIF BIO PLC/S alerts: Email Address Ad DTIthe most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here About MOTIF BIO PLC/S Stock (NASDAQ:MTFB)Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.Read More Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. MTFB Stock News HeadlinesFebruary 3, 2024 | msn.comSmall-molecule A485 mobilizes white blood cells on demandNovember 3, 2023 | finance.yahoo.comROBIT PLC’S FINANCIAL INFORMATION AND ANNUAL GENERAL MEETING IN 2024March 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.August 9, 2023 | finance.yahoo.com4GLOBAL plc's (LON:4GBL) Stock Is Going Strong: Have Financials A Role To Play?August 2, 2023 | finance.yahoo.comIs There An Opportunity With Stelrad Group PLC's (LON:SRAD) 44% Undervaluation?June 13, 2023 | finance.yahoo.comDAVA - Endava plcMay 25, 2023 | finance.yahoo.comLacklustre Performance Is Driving NIOX Group Plc's (LON:NIOX) Low P/SApril 27, 2023 | morningstar.comCushman & Wakefield PLC CWK Stock QuoteMarch 28, 2024 | Crypto 101 Media (Ad)Major Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.February 22, 2023 | finance.yahoo.comEvli Plc: Financial Statements Bulletin January-December 2022February 13, 2023 | marketwatch.comEnzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Analysis with Key Players having Regional Statistics and Application Forecast to 2029February 13, 2023 | marketwatch.comLuciferase Assay Kits Market Trends and Opportunities and Forecast to 2028 with Top Countries DataFebruary 10, 2023 | wsj.comAccenture PLC Cl ANovember 16, 2022 | finance.yahoo.comConsti Plc's financial reporting and Annual General Meeting in 2023October 20, 2022 | marketwatch.comImmunoprotein Reagents and Assay Kits Market Research on Present State and Future Growth Prospects of Key Players, Forecast by 2022 To 2028October 3, 2022 | fool.co.ukMotif BioAugust 15, 2022 | finance.yahoo.comQ32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune DiseasesJuly 23, 2022 | apnews.comThe Worldwide Hemoglobin A1c Analyzer Industry is Expected to Reach $627 Million by 2027 - ResearchAndMarkets.comJuly 15, 2022 | yahoo.comManifold Bio's molecular 'barcodes' could break through pharma's in vivo bottleneckSee More Headlines Receive MTFB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MOTIF BIO PLC/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:MTFB CUSIPN/A CIK1674657 Webwww.motifbio.com Phone212-210-6248FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Graham George Lumsden (Age 59)CEO & Exec. Director Mr. Jonathan E. Gold (Age 46)CFO & Exec. Director Dr. David B. Huang (Age 44)Chief Medical Officer Mr. Robert Dickey IV (Age 63)Advisor Laurie DoyleHead of Investor Relations & Corp. CommunicationsKey CompetitorsGrifolsNASDAQ:GRFSLAVA TherapeuticsNASDAQ:LVTXMainz BiomedNASDAQ:MYNZNLS PharmaceuticsNASDAQ:NLSPPharvarisNASDAQ:PHVSView All Competitors MTFB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of MOTIF BIO PLC/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other MOTIF BIO PLC/S investors own include Sorrento Therapeutics (SRNE), Allergan (AGN), Ampliphi Biosciences (APHB), Neurocrine Biosciences (NBIX), Forward Pharma A/S (FWP), Novartis (NVS), SDX Energy (SDX), Block (SQ) and Adaptimmune Therapeutics (ADAP). When did MOTIF BIO PLC/S IPO? MOTIF BIO PLC/S (MTFB) raised $17 million in an IPO on Friday, November 18th 2016. The company issued 2,400,000 shares at a price of $6.98 per share. H.C. Wainwright & Co. served as the underwriter for the IPO. This page (NASDAQ:MTFB) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MOTIF BIO PLC/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.